Search results
Author(s):
Hongwu Chen
,
Kit Chan
,
Sunny S Po
,
et al
Added:
3 years ago
Ventricular tachycardia (VT) originating from the Purkinje system is the most common type of idiopathic left ventricular tachycardia (ILVT), especially among young Asians.1,2 It usually has a benign course. Research over the past two decades has deepened our understanding of the anatomy of the Purkinje system and the mechanisms of ILVT. This review focuses on the research history and anatomy of…
View more
Author(s):
C Fielder Camm
,
A John Camm
Added:
3 years ago
Hypertrophic cardiomyopathy (HCM) is a common genetic cardiac disorder, with an autosomal dominant mechanism of inheritance.1,2 It has a prevalence of 1 in 500 within the general population, and is a known cause of sudden cardiac death.2,3 Recognised autosomal dominant mutations within sarcomere proteins are found in 55 % of adolescents with sporadic HCM.4 Characteristic echocardiographic…
View more
Author(s):
Peter J Schwartz
Added:
3 years ago
Despite the clear improvements in clinical outcomes brought about by medical therapy with β-blockers, ACE inhibitors and aldosterone antagonists, as well as by device therapy with cardiac resynchronisation, many patients with chronic heart failure (HF) remain symptomatic despite optimal medical therapy. Symptomatic HF can have devastating consequences for the quality of life of individuals, and…
View more
Author(s):
Harriette Van Spall
,
Clyde W Yancy
Added:
9 months ago
Join Masterclass host, Dr. Harriette Van Spall (McMaster University, CA), in an in-depth interview with Dr. Clyde W. Yancy (Northwestern University, US).
Dr. Yancy, an internationally respected leader and mentor in cardiology, holds positions as the Vice Dean of Diversity and Inclusion, Magerstadt Professor of Medicine, and Chief of the Division of Cardiology at Northwestern University's…
View more
Update in Cardiac Pacing
Author(s):
Nishant Verma
,
Bradley P Knight
Added:
3 years ago
Article
Author(s):
Oliver Plunkett
,
Gregory YH Lip
Added:
3 years ago
The introduction of novel oral anticoagulants (NOACs) has widened the treatment options for oral anticoagulation in stroke prevention in non-valvular atrial fibrillation (AF). Guidelines for the management of non-valvular AF have changed to reflect the emerging evidence of their relative safety and efficacy compared with warfarin (see Table 1).1–6
Download original
NOACs are now licensed for…
View more
The Convergent Procedure
Author(s):
James McKinnie
Added:
3 years ago
Article
Electrical Mapping to Optimise Heart Failure Outcomes Following Cardiac Resynchronisation Therapy
Author(s):
David O’Donnell
Added:
8 years ago
Article
Added:
6 years ago
Author(s):
Sotiris C Plastiras
,
Haralampos M Moutsopoulos
Added:
2 years ago